Towards the Development of Long Circulating Phosphatidylserine (PS)- and Phosphatidylglycerol (PG)-Enriched Anti-Inflammatory Liposomes: Is PEGylation Effective?
The anionic phospholipids (PLs) phosphatidylserine (PS) and phosphatidylglycerol (PG) are endogenous phospholipids with anti-inflammatory and immunomodulatory activity. A potential clinical use requires well-defined systems and for several applications, a long circulation time is desirable. Therefor...
Saved in:
Main Authors: | Miriam E. Klein (Author), Max Rieckmann (Author), Daniel Sedding (Author), Gerd Hause (Author), Annette Meister (Author), Karsten Mäder (Author), Henrike Lucas (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphatidylglycerol to Treat Chronic Skin Wounds in Diabetes
by: Yonghong Luo, et al.
Published: (2023) -
Phosphatidylserine-Gold Nanoparticles (PS-AuNP) Induce Prostate and Breast Cancer Cell Apoptosis
by: Allan Radaic, et al.
Published: (2021) -
A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes
by: Manjarika De, et al.
Published: (2018) -
Pegylated liposomal doxorubicin in ovarian cancer
by: Robert Strother, et al.
Published: (2009) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
by: Gabriella Ferrandina, et al.
Published: (2010)